Car T Cells Secreting an Immune Checkpoint Blockade scFv Have Enhanced Anti-Tumor Efficacy

被引：0
|
作者：
Rafiq, Sarwish [1 ]
Yeku, Oladapo [1 ]
Jackson, Hollie [1 ]
Purdon, Terence [1 ]
van Leeuwen, Dayenne [1 ]
Yan, Su [2 ]
Wang, Pei [2 ]
Xiang, Jingyi [2 ]
Liu, Cheng [2 ]
Brentjens, Renier [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Eureka Therapeut, Emeryville, CA USA
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
966
引用
收藏
页码：439 / 440
页数：2
相关论文
共 50 条
  • [41] Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade
    Belcaid, Laila
    Garaud, Soizic
    Kerger, Joseph
    Spyridon, Sideris
    Aspeslagh, Sandrine
    ACTA CLINICA BELGICA, 2021, 76 (02) : 144 - 148
  • [42] Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
    Andersson, Patrik
    Ostheimer, Christian
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [43] FF-10832 combined with immune checkpoint blockade shows favorable anti-tumor activity
    Ioroi, Tadaaki
    Komori, Takashi
    Matsumoto, Takeshi
    Shimoyama, Susumu
    Kobayashi, Takayuki
    Murao, Hidetoshi
    Watanabe, Shinichi
    Hagiwara, Shinji
    Hara, Takefumi
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Brachytherapy dose heterogeneity primes response to immune checkpoint blockade to generate anti-tumor immunity
    Jagodinsky, Justin C.
    Jin, Wonjong
    Vera, Jessica M.
    Sriramaneni, Raghava N.
    Clark, Paul A.
    Lan, Keng-Hsueh S.
    Chakravarty, Ishan
    Siegel, Noah
    Allawi, Raad H.
    Emma, Sarah E.
    Arthur, Ian S.
    Das, Rupak K.
    Ong, Irene M.
    Miller, Jessica R.
    Morris, Zachary S.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade
    Zhao, Xinrui
    Shao, Chunlin
    CANCERS, 2020, 12 (10) : 1 - 20
  • [46] IMMUNE CHECKPOINT BLOCKADE ENHANCES CYCLOPHOSPHAMIDE INDUCED ANTI-TUMOR IMMUNITY IN A PRECLINICAL MELANOMA MODEL
    George, Mariam
    Betof, Allison
    Merghoub, Taha
    Hamadene, Linda
    Hirschhorn, Daniel
    Houghton, Alan
    Wolchok, Jedd
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A824 - A824
  • [47] SIRP? DEFICIENT CAR-MACROPHAGES EXHIBIT ENHANCED ANTI-TUMOR FUNCTION AND BYPASS THE CD47 IMMUNE CHECKPOINT
    Sloas, Chris
    Gabbasov, Rashid
    Anderson, Nicholas
    Abramson, Sascha
    Klichinsky, Michael
    Ohtani, Yumi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A152 - A152
  • [48] ARMORED CAR T CELLS SECRETING 4-1BB LIGAND CROSSLINKED TO PD-1 CHECKPOINT INHIBITOR FOR ENHANCED SOLID TUMOR EFFICACY
    Dunn, Zachary
    Qu, Yun
    MacMullan, Melanie
    Chen, Xianhui
    Cinay, Gunce
    Wang, Pin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A121 - A121
  • [49] Tumor cell-derived lactic acid inhibit anti-tumor immunity in the immune checkpoint blockade resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Sun, Ruoxuan
    Lim, Seung-Oe
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [50] Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy
    Pelly, Victoria S.
    Moeini, Agrin
    Roelofsen, Lisanne M.
    Bonavita, Eduardo
    Bell, Charlotte R.
    Hutton, Colin
    Blanco-Gomez, Adrian
    Banyard, Antonia
    Bromley, Christian P.
    Flanagan, Eimear
    Chiang, Shih-Chieh
    Jorgensen, Claus
    Schumacher, Ton N.
    Thommen, Daniela S.
    Zelenay, Santiago
    CANCER DISCOVERY, 2021, 11 (10) : 2602 - 2619
12345